Mersana Therapeutics, Inc. (MRSN)
After hours:
| Previous close | 2.2100 |
| Open | 2.1900 |
| Bid | 2.0900 x 400 |
| Ask | 2.1500 x 200 |
| Day's range | 2.0700 - 2.1900 |
| 52-week range | 0.8010 - 6.2800 |
| Volume | |
| Avg. volume | 1,725,009 |
| Market cap | 256.958M |
| Beta (5Y monthly) | 1.49 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.1200 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.57 |
GlobeNewswireMersana Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that members of management will present at the following upcoming investor conferences: TD Cowen 5th Annual Oncology Innovation SummitFormat: Fireside chatDate/Time: Wednesday, May 29, 2024, at 9:00 a.m. East
Simply Wall St.Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mersana Therapeutics, Inc. ( NASDAQ:MRSN ) just released its quarterly report and things are looking bullish. Revenues...
Insider MonkeyMersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript May 9, 2024 Mersana Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Mersana Therapeutics First Quarter 2024 Conference Call and Webcast. Currently, all […]
